Click on the protein name for more information about the protein.
The Score column is the predicted score of interaction between the two proteins
Click on the Evidence link to view a breakdown of the information about the predicted interaction.
| Key | |
|---|---|
| Module Score | Databases |
![]() | Where interaction is observed in another database a link is provided: |
| Protein 1 (?) | Protein 2 (?) | Name of Protein 2 | Module Scores (?) | Scores (?) | Evidence (?) | Database (?) | |||
|---|---|---|---|---|---|---|---|---|---|
![]() | ![]() | ![]() | ![]() | ||||||
| CTTN | ACTG1 | ACTB: Actin, cytoplasmic 1 | 535.0 | Evidence | |||||
| CTTN | GRB2 | GRB2, ASH: Growth factor receptor-bound protein 2 | 384.0 | Evidence |
|
||||
| CTTN | CRKL | CRKL: Crk-like protein | 331.0 | Evidence | |||||
| CTTN | NCK1 | NCK1, NCK: Cytoplasmic protein NCK1 | 310.0 | Evidence | |||||
| CTTN | HCK | N/A | 256.0 | Evidence | |||||
| CTTN | FGR | FGR, SRC2: Proto-oncogene tyrosine-protein kinase FGR | 203.0 | Evidence | |||||
| CTTN | VAV1 | VAV1, VAV: Proto-oncogene vav | 181.0 | Evidence | |||||
| CTTN | CRK | N/A | 120.0 | Evidence | |||||
| CTTN | SYNJ1 | SYNJ1, KIAA0910: Synaptojanin-1 | 59.80 | Evidence | |||||
| CTTN | SYNJ2 | SYNJ2, KIAA0348: Synaptojanin-2 | 56.30 | Evidence | |||||
| CTTN | PDGFRB | PDGFRB: Beta-type platelet-derived growth factor receptor precursor | 28.70 | Evidence | |||||
| CTTN | ABL1 | ABL1, ABL, JTK7: Proto-oncogene tyrosine-protein kinase ABL1 | 22.80 | Evidence | |||||
| CTTN | PIK3R2 | PIK3R2: Phosphatidylinositol 3-kinase regulatory subunit beta | 17.30 | Evidence | |||||
| CTTN | PAK4 | PAK4, KIAA1142: Serine/threonine-protein kinase PAK 4 | 17.30 | Evidence | |||||
| CTTN | DAB2 | DAB2, DOC2: Disabled homolog 2 | 17.30 | Evidence | |||||
| CTTN | SNTA1 | SNTA1, SNT1: Alpha-1-syntrophin | 17.30 | Evidence | |||||
| CTTN | WAS | WAS, IMD2: Wiskott-Aldrich syndrome protein | 16.00 | Evidence | |||||
| CTTN | EPHB2 | EPHB2, DRT, EPHT3, EPTH3, ERK, HEK5, TYRO5: Ephrin type-B receptor 2 precursor | 15.00 | Evidence | |||||
| CTTN | TEK | TEK, TIE2: Angiopoietin-1 receptor precursor | 15.00 | Evidence | |||||
| CTTN | CBLC | CBLC, CBL3, RNF57: Signal transduction protein CBL-C | 15.00 | Evidence | |||||
| CTTN | PTK2B | PTK2B, FAK2, PYK2, RAFTK: Protein tyrosine kinase 2 beta | 15.00 | Evidence | |||||
| CTTN | NF2 | NF2, SCH: Merlin | 15.00 | Evidence | |||||
| CTTN | LNK | SH2B3, LNK: SH2B adapter protein 3 | 15.00 | Evidence | |||||
| CTTN | PTPN6 | PTPN6, HCP, PTP1C: Tyrosine-protein phosphatase non-receptor type 6 | 15.00 | Evidence | |||||
| CTTN | STAT3 | 15.00 | Evidence | ||||||
| CTTN | ITK | ITK, EMT, LYK: Tyrosine-protein kinase ITK/TSK | 15.00 | Evidence | |||||
| CTTN | RASA1 | RASA1, RASA: Ras GTPase-activating protein 1 | 15.00 | Evidence | |||||
| CTTN | FRS3 | FRS3: Fibroblast growth factor receptor substrate 3 | 13.80 | Evidence | |||||
| CTTN | WASL | WASL: Neural Wiskott-Aldrich syndrome protein | 13.70 | Evidence |
|
||||
| CTTN | KHDRBS1 | KHDRBS1, SAM68: KH domain-containing, RNA-binding, signal transduction-associate | 12.60 | Evidence | |||||
| CTTN | ERBB2 | ERBB2, HER2, NEU, NGL: Receptor tyrosine-protein kinase erbB-2 precursor | 11.40 | Evidence | |||||
| CTTN | MET | MET: Hepatocyte growth factor receptor precursor | 11.40 | Evidence |
|
||||
| CTTN | ITGB4 | N/A | 11.40 | Evidence | |||||
| CTTN | EPHA2 | EPHA2, ECK: Ephrin type-A receptor 2 precursor | 11.40 | Evidence | |||||
| CTTN | IRS4 | IRS4, RP6-24A23.4-001, hCG_20762: Insulin receptor substrate 4 | 11.20 | Evidence | |||||
| CTTN | WASPIP | N/A | 10.80 | Evidence |
|
||||
| CTTN | BLNK | BLNK, BASH, SLP65: B-cell linker protein | 10.00 | Evidence | |||||
| CTTN | JAK1 | 10.00 | Evidence | ||||||
| CTTN | ZAP70 | ZAP70: Uncharacterized protein ZAP70 | 10.00 | Evidence | |||||
| CTTN | CD247 | CD247, CD3Z, T3Z, TCRZ: T-cell surface glycoprotein CD3 zeta chain precursor | 9.92 | Evidence | |||||
| CTTN | ERBB3 | ERBB3, HER3: Receptor tyrosine-protein kinase erbB-3 precursor | 9.92 | Evidence | |||||
| CTTN | FGFR3 | FGFR3, JTK4: Fibroblast growth factor receptor 3 precursor | 9.92 | Evidence | |||||
| CTTN | LAT | LAT: Linker for activation of T-cells family member 1 | 9.92 | Evidence | |||||
| CTTN | TRPM7 | TRPM7, CHAK1, LTRPC7: Transient receptor potential cation channel subfamily M me | 9.92 | Evidence | |||||
| CTTN | FGFR1 | FGFR1, FGFBR, FLG, FLT2: Basic fibroblast growth factor receptor 1 precursor | 9.92 | Evidence | |||||
| CTTN | ADAM15 | ADAM15, MDC15: ADAM 15 precursor | 9.92 | Evidence | |||||
| CTTN | RET | RET: Proto-oncogene tyrosine-protein kinase receptor ret precursor | 9.92 | Evidence | |||||
| CTTN | AXL | AXL, UFO: Tyrosine-protein kinase receptor UFO precursor | 9.92 | Evidence | |||||
| CTTN | SRC | SRC, SRC1: Proto-oncogene tyrosine-protein kinase Src | 9.89 | Evidence |
|
||||
| CTTN | IRS2 | IRS2: Insulin receptor substrate 2 | 9.89 | Evidence | |||||
| CTTN | DAB1 | DAB1: Disabled homolog 1 | 9.89 | Evidence | |||||
| CTTN | GAB1 | GAB1: GRB2-associated-binding protein 1 | 9.89 | Evidence | |||||
| CTTN | MST1R | MST1R, PTK8, RON: Macrophage-stimulating protein receptor precursor | 9.14 | Evidence | |||||
| CTTN | KDR | KDR, FLK1: Vascular endothelial growth factor receptor 2 precursor | 9.14 | Evidence | |||||
| CTTN | MSN | MSN: Moesin | 8.92 | Evidence | |||||
| CTTN | APS | SH2B2, APS: SH2B adapter protein 2 | 8.92 | Evidence | |||||
| CTTN | LYN | LYN: Tyrosine-protein kinase Lyn | 7.97 | Evidence | |||||
| CTTN | SYK | SYK: Tyrosine-protein kinase SYK | 7.97 | Evidence |
|
||||
| CTTN | MAP4K1 | MAP4K1, HPK1: Mitogen-activated protein kinase kinase kinase kinase 1 | 7.97 | Evidence | |||||
| CTTN | BTK | BTK, AGMX1, ATK, BPK: Tyrosine-protein kinase BTK | 7.97 | Evidence | |||||
| CTTN | SH3BP2 | SH3BP2: Uncharacterized protein SH3BP2 | 7.97 | Evidence | |||||
| CTTN | SLA | SLA, SLAP, SLAP1: SRC-like-adapter | 7.97 | Evidence | |||||
| CTTN | RPS6KA1 | RPS6KA1, RSK1: Ribosomal protein S6 kinase alpha-1 | 7.97 | Evidence | |||||
| CTTN | PIK3CG | PIK3CG: Phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma i | 7.97 | Evidence | |||||
| CTTN | ADRBK1 | ADRBK1, BARK, BARK1, GRK2: Beta-adrenergic receptor kinase 1 | 7.97 | Evidence | |||||
| CTTN | SOS1 | SOS1: Son of sevenless homolog 1 | 7.71 | Evidence | |||||
| CTTN | CDC2L2 | CDC2L2, CDC2L3, PITSLREB: PITSLRE serine/threonine-protein kinase CDC2L2 | 7.59 | Evidence | |||||
| CTTN | MERTK | MERTK, MER: Proto-oncogene tyrosine-protein kinase MER precursor | 7.40 | Evidence | |||||
| CTTN | EPHB1 | EPHT2, EPHB1, NET: Ephrin type-B receptor 1 precursor | 7.40 | Evidence | |||||
| CTTN | SCML2 | SCML2: Sex comb on midleg-like protein 2 | 7.40 | Evidence | |||||
| CTTN | FLT1 | FLT1, FLT, FRT: Vascular endothelial growth factor receptor 1 precursor | 7.40 | Evidence | |||||
| CTTN | CBLB | CBLB, RNF56, Nbla00127: E3 ubiquitin-protein ligase CBL-B | 6.89 | Evidence | |||||
| CTTN | SH3KBP1 | SH3KBP1, CIN85: SH3 domain-containing kinase-binding protein 1 | 6.80 | Evidence | |||||
| CTTN | YES1 | YES1, YES: Proto-oncogene tyrosine-protein kinase Yes | 6.78 | Evidence | |||||
| CTTN | ANXA2 | ANXA2, ANX2, ANX2L4, CAL1H, LPC2D: Annexin A2 | 6.76 | Evidence | |||||
| CTTN | APEX1 | APEX1, APE, APEX, APX, HAP1, REF1: DNA-(apurinic or apyrimidinic site) lyase | 6.62 | Evidence | |||||
| CTTN | CD28 | CD28: T-cell-specific surface glycoprotein CD28 precursor | 6.62 | Evidence | |||||
| CTTN | CD58 | CD58, LFA3: Lymphocyte function-associated antigen 3 precursor | 6.62 | Evidence | |||||
| CTTN | CD22 | CD22, SIGLEC2: B-cell receptor CD22 precursor | 6.62 | Evidence | |||||
| CTTN | CD3D | CD3D, T3D: T-cell surface glycoprotein CD3 delta chain precursor | 6.62 | Evidence | |||||
| CTTN | KIT | KIT: Mast/stem cell growth factor receptor precursor | 6.52 | Evidence | |||||
| CTTN | EPOR | EPOR: Erythropoietin receptor precursor | 6.52 | Evidence | |||||
| CTTN | GHR | GHR: Growth hormone receptor precursor | 6.52 | Evidence | |||||
| CTTN | FASLG | FASLG, APT1LG1, FASL, TNFSF6: Tumor necrosis factor ligand superfamily member 6 | 6.52 | Evidence | |||||
| CTTN | FLT3 | FLT3, STK1: FL cytokine receptor precursor | 5.88 | Evidence | |||||
| CTTN | CSF1R | CSF1R, FMS: Macrophage colony-stimulating factor 1 receptor precursor | 5.88 | Evidence | |||||
| CTTN | CBL | CBL, CBL2, RNF55: E3 ubiquitin-protein ligase CBL | 5.88 | Evidence | |||||
| CTTN | IL2RB | IL2RB: Interleukin-2 receptor subunit beta precursor | 5.88 | Evidence | |||||
| CTTN | NULL | N/A | 5.81 | Evidence | |||||
| CTTN | LCP2 | LCP2: Lymphocyte cytosolic protein 2 | 5.25 | Evidence | |||||
| CTTN | TOM1L1 | TOM1L1, SRCASM: TOM1-like protein 1 | 5.17 | Evidence | |||||
| CTTN | SGK | SGK, SGK1: Serine/threonine-protein kinase Sgk1 | 5.07 | Evidence | |||||
| CTTN | HD | HD, IT15: Huntingtin | 5.07 | Evidence | |||||
| CTTN | SVIL | SVIL: Supervillin | 4.76 | Evidence | |||||
| CTTN | SHC1 | SHC1, RP11-307C12.1-001, hCG_1997126: SHC | 4.73 | Evidence | |||||
| CTTN | C6orf21 | LY6G6F, C6orf21, G6F, LY6G6D, NG32: Lymphocyte antigen 6 complex locus protein G | 4.68 | Evidence | |||||
| CTTN | SYN1 | SYN1: Synapsin-1 | 4.68 | Evidence | |||||
| CTTN | CD2AP | CD2AP: CD2-associated protein | 4.54 | Evidence | |||||
| CTTN | FXR1 | FXR1: Fragile X mental retardation syndrome-related protein 1 | 4.50 | Evidence | |||||
| CTTN | SYTL4 | Endocrine transmitter regulatory protein | 4.48 | Evidence | |||||
| CTTN | MAPK12 | MAPK12, ERK6, SAPK3: Mitogen-activated protein kinase 12 | 4.47 | Evidence | |||||
| CTTN | FABP4 | FABP4: Fatty acid-binding protein, adipocyte | 4.38 | Evidence | |||||
| CTTN | FRS2 | FRS2: Fibroblast growth factor receptor substrate 2 | 4.31 | Evidence | |||||
| CTTN | ACTR3 | ACTR3, ARP3: Actin-related protein 3 | 4.04 | Evidence |
O
|
||||
| CTTN | H2-ALPHA | TUBA3C, TUBA2, TUBA3D: Tubulin alpha-3C/D chain | 4.01 | Evidence | |||||
| CTTN | PTPRE | PTPRE: Receptor-type tyrosine-protein phosphatase epsilon precursor | 4.01 | Evidence | |||||
| CTTN | FYN | FYN: Proto-oncogene tyrosine-protein kinase Fyn | 3.65 | Evidence | |||||
| CTTN | PDE6G | DKFZp686N1686, PDE6G, hCG_38056: Putative uncharacterized protein DKFZp686N1686 | 3.49 | Evidence | |||||
| CTTN | TAGLN | TAGLN, SM22, WS3-10: Transgelin | 3.42 | Evidence | |||||
| CTTN | ALOX5 | ALOX5, LOG5: Arachidonate 5-lipoxygenase | 3.17 | Evidence | |||||
| CTTN | PTPN1 | PTP1B, PTPN1: Tyrosine-protein phosphatase non-receptor type 1 | 2.98 | Evidence | |||||
| CTTN | NEK9 | NEK9, KIAA1995, NEK8, NERCC: Serine/threonine-protein kinase Nek9 | 2.98 | Evidence | |||||
| CTTN | SHC3 | SHC3, NSHC, SHCC: SHC-transforming protein 3 | 2.93 | Evidence | |||||
| CTTN | CNN3 | CNN3: Calponin-3 | 2.80 | Evidence | |||||
| CTTN | EGF | EGF: Pro-epidermal growth factor precursor | 2.71 | Evidence | |||||
| CTTN | ADRB2 | ADRB2, ADRB2R, B2AR: Beta-2 adrenergic receptor | 2.65 | Evidence | |||||
| CTTN | CFL1 | CFL1, CFL: Cofilin-1 | 2.63 | Evidence | |||||
| CTTN | CSNK1E | CSNK1E: Casein kinase I isoform epsilon | 2.56 | Evidence | |||||
| CTTN | DCTN1 | DCTN1: Dynactin subunit 1 | 2.54 | Evidence | |||||
| CTTN | GPRASP2 | GPRASP2: G-protein coupled receptor-associated sorting protein 2 | 2.54 | Evidence | |||||
| CTTN | CARHSP1 | CARHSP1: Calcium-regulated heat stable protein 1 | 2.54 | Evidence | |||||
| CTTN | CPNE1 | RBM12, KIAA0765, HRIHFB2091: RNA-binding protein 12 | 2.54 | Evidence | |||||
| CTTN | SIVA | SIVA1, SIVA: Apoptosis regulatory protein Siva | 2.54 | Evidence | |||||
| CTTN | CDC42 | N/A | 2.54 | Evidence | |||||
| CTTN | BCR | N/A | 2.54 | Evidence | |||||